DE602006007219D1 - Pyroglutamatsalze und deren verwendung bei der optischen trennung von zwischenprodukten für die synthese von dextrocetirizin und levocetirizin - Google Patents
Pyroglutamatsalze und deren verwendung bei der optischen trennung von zwischenprodukten für die synthese von dextrocetirizin und levocetirizinInfo
- Publication number
- DE602006007219D1 DE602006007219D1 DE602006007219T DE602006007219T DE602006007219D1 DE 602006007219 D1 DE602006007219 D1 DE 602006007219D1 DE 602006007219 T DE602006007219 T DE 602006007219T DE 602006007219 T DE602006007219 T DE 602006007219T DE 602006007219 D1 DE602006007219 D1 DE 602006007219D1
- Authority
- DE
- Germany
- Prior art keywords
- chlorobenzhydryl
- piperazin
- dextrocetirizine
- synthesis
- intermediates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05004653 | 2005-03-03 | ||
PCT/EP2006/001676 WO2006094648A1 (en) | 2005-03-03 | 2006-02-23 | Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006007219D1 true DE602006007219D1 (de) | 2009-07-23 |
Family
ID=34934038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006007219T Active DE602006007219D1 (de) | 2005-03-03 | 2006-02-23 | Pyroglutamatsalze und deren verwendung bei der optischen trennung von zwischenprodukten für die synthese von dextrocetirizin und levocetirizin |
Country Status (16)
Country | Link |
---|---|
US (1) | US7619085B2 (de) |
EP (1) | EP1858866B1 (de) |
JP (2) | JP2008531620A (de) |
KR (1) | KR101239795B1 (de) |
CN (1) | CN101128446B (de) |
AT (1) | ATE433444T1 (de) |
AU (1) | AU2006222298B2 (de) |
CA (1) | CA2599498C (de) |
DE (1) | DE602006007219D1 (de) |
EA (2) | EA012575B1 (de) |
ES (1) | ES2326689T3 (de) |
IL (1) | IL184518A (de) |
MX (1) | MX2007010455A (de) |
NZ (1) | NZ556580A (de) |
PL (1) | PL1858866T3 (de) |
WO (1) | WO2006094648A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2167479B1 (de) | 2007-06-15 | 2013-09-11 | Symed Labs Limited | Verfahren zur herstellung von weitgehend optisch reinen levorotatorischen und dextrorotatorischen enantiomeren von cetirizin mittels neuer zwischenprodukte |
KR100954755B1 (ko) * | 2007-12-17 | 2010-04-27 | 한미약품 주식회사 | (r)-(-)-1-[(4-클로로페닐)페닐메틸]피페라진의 제조방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8827391D0 (en) * | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride |
JP2995704B2 (ja) * | 1989-02-17 | 1999-12-27 | 東京化成工業株式会社 | 光学活性な1h−3−アミノピロリジン化合物の製造法 |
ATE170749T1 (de) * | 1992-09-24 | 1998-09-15 | Sepracor Inc | Verwendung von (-) cetirizin zur behandlung allergischer rhinitis und und asthma |
GB9305282D0 (en) * | 1993-03-15 | 1993-05-05 | Ucb Sa | Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine |
AU2004205494B2 (en) * | 2003-01-23 | 2009-04-30 | Ucb Farchim Sa | Piperazine derivatives and their use as synthesis intermediates |
KR100503443B1 (ko) * | 2004-02-02 | 2005-07-22 | 한림제약(주) | 광학적으로 활성인 세티리진 또는 그의 염의 제조방법 |
US7989623B2 (en) * | 2007-11-21 | 2011-08-02 | Synthon Bv | Process for making n-(diphenylmethyl)piperazines |
-
2006
- 2006-02-23 KR KR1020077022518A patent/KR101239795B1/ko not_active IP Right Cessation
- 2006-02-23 EA EA200701818A patent/EA012575B1/ru not_active IP Right Cessation
- 2006-02-23 CA CA2599498A patent/CA2599498C/en not_active Expired - Fee Related
- 2006-02-23 MX MX2007010455A patent/MX2007010455A/es active IP Right Grant
- 2006-02-23 PL PL06707220T patent/PL1858866T3/pl unknown
- 2006-02-23 US US11/817,320 patent/US7619085B2/en not_active Expired - Fee Related
- 2006-02-23 NZ NZ556580A patent/NZ556580A/en not_active IP Right Cessation
- 2006-02-23 DE DE602006007219T patent/DE602006007219D1/de active Active
- 2006-02-23 AU AU2006222298A patent/AU2006222298B2/en not_active Ceased
- 2006-02-23 WO PCT/EP2006/001676 patent/WO2006094648A1/en active Application Filing
- 2006-02-23 CN CN2006800056871A patent/CN101128446B/zh not_active Expired - Fee Related
- 2006-02-23 JP JP2007557385A patent/JP2008531620A/ja active Pending
- 2006-02-23 EA EA200900359A patent/EA014248B1/ru not_active IP Right Cessation
- 2006-02-23 EP EP06707220A patent/EP1858866B1/de active Active
- 2006-02-23 ES ES06707220T patent/ES2326689T3/es active Active
- 2006-02-23 AT AT06707220T patent/ATE433444T1/de not_active IP Right Cessation
-
2007
- 2007-07-10 IL IL184518A patent/IL184518A/en not_active IP Right Cessation
-
2012
- 2012-10-12 JP JP2012226914A patent/JP2013032380A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2599498C (en) | 2011-06-21 |
EA014248B1 (ru) | 2010-10-29 |
MX2007010455A (es) | 2007-11-08 |
ES2326689T3 (es) | 2009-10-16 |
JP2013032380A (ja) | 2013-02-14 |
CN101128446A (zh) | 2008-02-20 |
AU2006222298A1 (en) | 2006-09-14 |
US20080269489A1 (en) | 2008-10-30 |
JP2008531620A (ja) | 2008-08-14 |
EP1858866A1 (de) | 2007-11-28 |
US7619085B2 (en) | 2009-11-17 |
PL1858866T3 (pl) | 2009-11-30 |
ATE433444T1 (de) | 2009-06-15 |
EA200900359A1 (ru) | 2009-06-30 |
KR20070113272A (ko) | 2007-11-28 |
NZ556580A (en) | 2009-08-28 |
EA200701818A1 (ru) | 2008-02-28 |
IL184518A0 (en) | 2007-10-31 |
KR101239795B1 (ko) | 2013-03-06 |
EP1858866B1 (de) | 2009-06-10 |
AU2006222298B2 (en) | 2011-02-24 |
EA012575B1 (ru) | 2009-10-30 |
CA2599498A1 (en) | 2006-09-14 |
IL184518A (en) | 2010-11-30 |
CN101128446B (zh) | 2010-12-08 |
WO2006094648A1 (en) | 2006-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200701756A1 (ru) | Соль производного пролина, её сольват и способ её получения | |
ES2527794T3 (es) | Procedimiento para preparar compuestos de benzazepina o sus sales | |
Edraki et al. | Phenylimino-2H-chromen-3-carboxamide derivatives as novel small molecule inhibitors of β-secretase (BACE1) | |
CY1119076T1 (el) | Αλατα πιπεραζινης ως ανταγωνιστες των d3/d2 | |
ATE381559T1 (de) | Adamantan- und azabicyclooctan- und - nonanderivate, verfahren zu deren herstellung und deren verwendung als dpp-iv-inhibitoren | |
ATE361924T1 (de) | Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
ATE525351T1 (de) | Substituierte n-phenyl- bipyrrolidincarbonsäureamide und deren therapeutische verwendung | |
ATE449090T1 (de) | Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren | |
DE602004030334D1 (de) | Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen | |
ATE496022T1 (de) | Anthranilsäure-derivat als antikrebswirkstoff und verfahren zur herstellung davon | |
ATE525350T1 (de) | Substituierte n-phenyl- bipyrrolidincarbonsäureamide und deren therapeutische verwendung | |
NZ606700A (en) | Process for manufacturing dihydropteridinones and intermediates thereof | |
ATE398121T1 (de) | Neue synthese von irbesartan | |
ES2370748T3 (es) | PIRIMIDIL-PIPERAZINAS ÚTILES COMO LIGANDOS DEL RECEPTOR D3/D2 DE LA DOPAMINA. | |
ATE449767T1 (de) | Industrielles verfahren zur herstellung von 5- bis(carboxymethyl)amino -3-carboxymethyl-4-cyano-2-thiophencarbonsäure- etraestern und verwendung zur synthese von zweiwertigen ranetansäuresalzen und deren hydraten | |
DE602006007219D1 (de) | Pyroglutamatsalze und deren verwendung bei der optischen trennung von zwischenprodukten für die synthese von dextrocetirizin und levocetirizin | |
Donnier-Marechal et al. | Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands | |
EA200600061A1 (ru) | Бензамиды 4-(аминометил) пиперидина как 5нт-антагонисты | |
Lovell et al. | N-Acyl-N′-arylpiperazines as negative allosteric modulators of mGlu1: Identification of VU0469650, a potent and selective tool compound with CNS exposure in rats | |
BR0312593A (pt) | Aciluréias substituìdas por uréia e uretano, processo para a sua produção e sua aplicação | |
Hu et al. | Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists | |
HU0501138D0 (en) | Process for the production of a pharmaceutical intermediate | |
BRPI0414107A (pt) | produtos intermediários para a preparação de hìbridos de oxazolidinon-quinolona | |
DE602005005218D1 (de) | Kristalline form von cefdinir-ammoniumsalz als zwischenprodukt für die herstellung von reinem cefdinir | |
Manka et al. | Octahydropyrrolo [3, 4-c] pyrrole negative allosteric modulators of mGlu1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |